As cell therapies become more complex, scientists are having to reconsider their engineering approach to avoid increasing structural risk.
Inside this infographic:
Download your free copy now.
The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.
From 1 edit to 6: Why avoiding double-strand DNA breaks matters in cell therapy engineering